List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Neurologic Disorder Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurologic Disorder Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurologic Disorder Treatment Drug Overall Market Size
2.1 Global Neurologic Disorder Treatment Drug Market Size: 2021 VS 2028
2.2 Global Neurologic Disorder Treatment Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurologic Disorder Treatment Drug Players in Global Market
3.2 Top Global Neurologic Disorder Treatment Drug Companies Ranked by Revenue
3.3 Global Neurologic Disorder Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Neurologic Disorder Treatment Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neurologic Disorder Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Neurologic Disorder Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Neurologic Disorder Treatment Drug Market Size Markets, 2021 & 2028
4.1.2 Anticholinergic
4.1.3 Antiepileptic
4.1.4 Antipsychotic
4.1.5 Hypnotic and Sedative
4.1.6 Analgesics
4.1.7 Antihypertensive
4.1.8 Anticoagulants
4.1.9 Others
4.2 By Type - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
4.2.2 By Type - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
4.2.3 By Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurologic Disorder Treatment Drug Market Size, 2021 & 2028
5.1.2 Epilepsy
5.1.3 Alzheimer?s Disease
5.1.4 Parkinson's Disease
5.1.5 Multiple Sclerosis
5.1.6 Cerebrovascular Disease
5.1.7 Others
5.2 By Application - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
5.2.2 By Application - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
5.2.3 By Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Neurologic Disorder Treatment Drug Market Size, 2021 & 2028
6.2 By Region - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
6.2.2 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
6.2.3 By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Neurologic Disorder Treatment Drug Revenue, 2017-2028
6.3.2 US Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.3.3 Canada Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.3.4 Mexico Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Neurologic Disorder Treatment Drug Revenue, 2017-2028
6.4.2 Germany Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.3 France Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.4 U.K. Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.5 Italy Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.6 Russia Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.7 Nordic Countries Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4.8 Benelux Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Neurologic Disorder Treatment Drug Revenue, 2017-2028
6.5.2 China Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5.3 Japan Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5.4 South Korea Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5.5 Southeast Asia Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5.6 India Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Neurologic Disorder Treatment Drug Revenue, 2017-2028
6.6.2 Brazil Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.6.3 Argentina Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, 2017-2028
6.7.2 Turkey Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.7.3 Israel Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.7.5 UAE Neurologic Disorder Treatment Drug Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Neurologic Disorder Treatment Drug Major Product Offerings
7.1.4 AbbVie Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Acadia Pharmaceuticals
7.2.1 Acadia Pharmaceuticals Corporate Summary
7.2.2 Acadia Pharmaceuticals Business Overview
7.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Major Product Offerings
7.2.4 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.2.5 Acadia Pharmaceuticals Key News
7.3 Acorda Therapeutics Biotechnology
7.3.1 Acorda Therapeutics Biotechnology Corporate Summary
7.3.2 Acorda Therapeutics Biotechnology Business Overview
7.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Major Product Offerings
7.3.4 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.3.5 Acorda Therapeutics Biotechnology Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neurologic Disorder Treatment Drug Major Product Offerings
7.4.4 Bayer Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.4.5 Bayer Key News
7.5 Biogen
7.5.1 Biogen Corporate Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Neurologic Disorder Treatment Drug Major Product Offerings
7.5.4 Biogen Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.5.5 Biogen Key News
7.6 CSK
7.6.1 CSK Corporate Summary
7.6.2 CSK Business Overview
7.6.3 CSK Neurologic Disorder Treatment Drug Major Product Offerings
7.6.4 CSK Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.6.5 CSK Key News
7.7 Eisai
7.7.1 Eisai Corporate Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Neurologic Disorder Treatment Drug Major Product Offerings
7.7.4 Eisai Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.7.5 Eisai Key News
7.8 F. Hoffmann La Roche
7.8.1 F. Hoffmann La Roche Corporate Summary
7.8.2 F. Hoffmann La Roche Business Overview
7.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Major Product Offerings
7.8.4 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.8.5 F. Hoffmann La Roche Key News
7.9 H Lundbeck
7.9.1 H Lundbeck Corporate Summary
7.9.2 H Lundbeck Business Overview
7.9.3 H Lundbeck Neurologic Disorder Treatment Drug Major Product Offerings
7.9.4 H Lundbeck Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.9.5 H Lundbeck Key News
7.10 Johnson and Johnson
7.10.1 Johnson and Johnson Corporate Summary
7.10.2 Johnson and Johnson Business Overview
7.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Major Product Offerings
7.10.4 Johnson and Johnson Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.10.5 Johnson and Johnson Key News
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Business Overview
7.11.3 Merck Neurologic Disorder Treatment Drug Major Product Offerings
7.11.4 Merck Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.11.5 Merck Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Business Overview
7.12.3 Novartis Neurologic Disorder Treatment Drug Major Product Offerings
7.12.4 Novartis Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.12.5 Novartis Key News
7.13 Otsuka Pharmaceutical
7.13.1 Otsuka Pharmaceutical Corporate Summary
7.13.2 Otsuka Pharmaceutical Business Overview
7.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
7.13.4 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.13.5 Otsuka Pharmaceutical Key News
7.14 Pfizer
7.14.1 Pfizer Corporate Summary
7.14.2 Pfizer Business Overview
7.14.3 Pfizer Neurologic Disorder Treatment Drug Major Product Offerings
7.14.4 Pfizer Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.14.5 Pfizer Key News
7.15 Sanofi
7.15.1 Sanofi Corporate Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Neurologic Disorder Treatment Drug Major Product Offerings
7.15.4 Sanofi Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.15.5 Sanofi Key News
7.16 Takeda Pharmaceutical
7.16.1 Takeda Pharmaceutical Corporate Summary
7.16.2 Takeda Pharmaceutical Business Overview
7.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
7.16.4 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.16.5 Takeda Pharmaceutical Key News
7.17 Teva Pharmaceutical Industries
7.17.1 Teva Pharmaceutical Industries Corporate Summary
7.17.2 Teva Pharmaceutical Industries Business Overview
7.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Major Product Offerings
7.17.4 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.17.5 Teva Pharmaceutical Industries Key News
7.18 UCB
7.18.1 UCB Corporate Summary
7.18.2 UCB Business Overview
7.18.3 UCB Neurologic Disorder Treatment Drug Major Product Offerings
7.18.4 UCB Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.18.5 UCB Key News
7.19 USWM
7.19.1 USWM Corporate Summary
7.19.2 USWM Business Overview
7.19.3 USWM Neurologic Disorder Treatment Drug Major Product Offerings
7.19.4 USWM Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
7.19.5 USWM Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
